US EditionTrump's Crackdown on Drug Ads Is Long Overdue
FDA targets deceptive pharmaceutical ads with 100 cease-and-desist orders and seizes 4.7 million unauthorized e-cigarettes worth $86.5 million, boosting consumer safety efforts.
- Last week, President Donald Trump signed an executive order reinstating 1990s-era regulations requiring drug ads to clearly disclose side effects in the United States.
- The order responds to widespread concern over ballooning pharmaceutical ad spending, which reached about $10.1 billion in 2024 amid evidence most promoted drugs offer minimal clinical benefit.
- Alongside stricter regulations, the FDA unveiled new measures targeting deceptive marketing directly aimed at consumers and has taken enforcement actions against approximately 100 pharmaceutical companies.
- FDA Commissioner Marty Makary stated that for an extended period, these advertisements have undermined the trust between doctors and patients and have generated unnecessary demand for medications, even when they are not clinically justified.
- The administration’s crackdown aims to reduce pharmaceutical influence on consumer behavior, but experts caution enforcement capacity may be limited due to prior agency layoffs.
15 Articles
15 Articles
Helena Independent Record
Trump's crackdown on drug ads is long overdue
The Trump administration’s crackdown on pharmaceutical ads is a welcome step toward lessening Big Pharma’s influence over conversations between patients and their doctors.
Comment: Trump’s crackdown on drug ads good start; more needed
HeraldNet.com HeraldNet.com - Everett and Snohomish County news from The Daily Herald in Everett, Washington Rolling back rules to earlier standards is good, but the FDA may not have the staffing to enforce it. Comment: Trump’s crackdown on drug ads good start; more needed Wire Service
Jarvis: This crackdown on drug ads is long overdue
Lisa Jarvis The Trump administration’s crackdown on pharmaceutical ads is a welcome step toward lessening Big Pharma’s influence over conversations between patients and their doctors. Americans are among the few people in the world bombarded with advertisements for medications most of us don’t need — New Zealand is the only other country that allows direct-to-consumer […]
FDA Cracks Down on Drug Ads, Seizes $86M in Illegal Vapes, Pushes Non-Opioid Pain Relief
WASHINGTON, D.C. — The Food and Drug Administration launched a series of major enforcement and transparency initiatives last week, ranging from cracking down on deceptive pharmaceutical advertising to seizing a record haul of illegal e-cigarettes and unveiling new tools to track adverse reactions from cosmetics. On Sept. 9, federal health officials announced reforms aimed at curbing misleading direct-to-consumer drug advertising. The FDA said it…
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
